Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5821885 | Antiviral Research | 2015 | 9 Pages |
Abstract
Our results showed that r4M2e.HSP70c rather than control groups, r4M2e, r4M2e + Alum, or rHSP70c, significantly elevated both longevity and serum level of the total M2e-specific IgG antibody, induced a Th1 skewed humoral and cellular immune responses, increased the level of IFN-γ in BALF, and promoted the proliferation of peripheral blood lymphocytes. Furthermore, a virus challenge experiment revealed that mice vaccinated with r4M2e.HSP70c limited the severity of influenza A disease by 100% survival rate, less sever body weight loss and delaying the onset of morbidity in mice for 2 days rather than other control groups. Here, we used r4M2e.HSP70c to stimulate M2e-specific antibody and cellular immune responses in Balb/C mice. The mHSP70c in the fusion form induced a long lasting Th1 skewed humoral and cellular immune responses against its associated protein. It seems anti-M2e antibodies limit viral replication and ameliorate influenza infection that allows the immune system to induce sterilizing HA-antibody against whole virion that leads to full protection against virulent influenza infection.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Mehran Dabaghian, Ali Mohammad Latifi, Majid Tebianian, Fariba Dabaghian, Seyyed Mahmoud Ebrahimi,